Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
57,056,058
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
23,423,158
-
Shares change
-
+1,527,265
-
Total reported value, excl. options
-
$311,606,739
-
Value change
-
+$19,718,386
-
Put/Call ratio
-
7.1%
-
Number of buys
-
44
-
Number of sells
-
21
-
Price
-
$13.30
Institutional Holders of Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS) as of Q1 2023
As of 31 Mar 2023 Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS) had 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 23,423,158 shares of stock of the company.
Largest 10 holders included FMR LLC, PERCEPTIVE ADVISORS LLC, Fairmount Funds Management LLC, Deep Track Capital, LP, Vivo Capital, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Altium Capital Management LP, VANGUARD GROUP INC, Logos Global Management LP, and Cormorant Asset Management, LP.
This table shows 66 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.